Reflux Study Group, Laryngopharyngeal Reflux Study Group of Young-Otolaryngologists of the International Federations of Oto-rhino-laryngological Societies (YO-IFOS), Paris, France.
Department of Otolaryngology-Head and Neck Surgery, Foch Hospital, School of Medicine, University Paris Saclay, Paris, France.
Laryngoscope. 2021 Oct;131(10):E2627-E2633. doi: 10.1002/lary.29604. Epub 2021 May 19.
OBJECTIVES/HYPOTHESIS: To investigate the prevalence and features of laryngopharyngeal reflux (LPR) in patients with primary burning mouth syndrome (BMS).
Prospective uncontrolled study.
Patients who visited our Departments of Otolaryngology-Head and Neck and Maxillofacial surgery with BMS were prospectively recruited from September 2018 to September 2020. Patients benefited from dental, maxillofacial, otolaryngological examinations, and hypopharyngeal-esophageal impedance pH-monitoring (HEMII-pH). Oral, pharyngeal, and laryngeal findings and symptoms were rated with Reflux Sign Assessment (RSA) and Reflux Symptom Score-12 (RSS-12). Patients were treated with a combination of diet, pantoprazole, and alginate.
From the 81 included patients, 76 reported >1 pharyngeal reflux events (93.8%), accounting for 35 (46.1%), 24 (31.6%), and 17 (22.3%) acid, mixed, and nonacid LPR, respectively. Thirty-two patients had both LPR and gastroesophageal reflux disease (GERD). Thirty-eight patients benefited from pepsin saliva measurement, which was positive in 86.8% of cases. The mean scores of mouth/tongue burning, RSS-12, and RSA significantly improved from pre- to post-treatment (P < .004). At 3-month post-treatment, 62.5% of patients reported an improvement of mouth/tongue burning score. Patients with both GERD and LPR reported higher baseline RSS-12 and RSA scores.
Acid, weakly acid, and nonacid LPR may be involved in the development of BMS. The use of an appropriate treatment considering the reflux features is associated with an improvement of symptoms and findings.
4 Laryngoscope, 131:E2627-E2633, 2021.
目的/假设:研究原发性灼口综合征(BMS)患者中咽喉反流(LPR)的患病率和特征。
前瞻性非对照研究。
2018 年 9 月至 2020 年 9 月,我们耳鼻喉头颈颌面外科门诊前瞻性招募了患有 BMS 的患者。患者接受了牙科、颌面、耳鼻喉检查和下咽食管阻抗 pH 监测(HEMII-pH)。使用反流症状评估(RSA)和反流症状评分-12(RSS-12)对口腔、咽部和喉部发现和症状进行评分。患者接受饮食、泮托拉唑和藻酸盐联合治疗。
81 例患者中,76 例患者报告 >1 次咽部反流事件(93.8%),其中酸反流、混合反流和非酸反流分别占 35(46.1%)、24(31.6%)和 17(22.3%)。32 例患者同时存在 LPR 和胃食管反流病(GERD)。38 例患者接受了胃蛋白酶唾液测量,其中 86.8%的病例呈阳性。治疗前和治疗后,口/舌烧灼感、RSS-12 和 RSA 的平均评分均显著改善(P < .004)。治疗 3 个月后,62.5%的患者报告口/舌烧灼感评分改善。同时存在 GERD 和 LPR 的患者的 RSS-12 和 RSA 基线评分较高。
酸、弱酸性和非酸性 LPR 可能参与 BMS 的发生。考虑反流特征的适当治疗与症状和发现的改善相关。
4 级喉镜,131:E2627-E2633,2021 年。